We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Smaller, Less Expensive Portable MRI Systems to Expand Applications in Various Health Care Settings

By MedImaging International staff writers
Posted on 19 Jul 2023
Print article
Image: New measurements aim to advance and validate portable MRI technology (Photo courtesy of NIST)
Image: New measurements aim to advance and validate portable MRI technology (Photo courtesy of NIST)

Magnetic Resonance Imaging (MRI) machines offer detailed views of the body's non-bony structures like the brain, muscles, and ligaments, and are instrumental in identifying tumors and diagnosing various ailments. Nonetheless, their high cost, bulkiness, and dependency on powerful magnets limit their availability, primarily to large healthcare facilities. In response to this, companies are designing portable MRI machines that rely on lower-strength magnetic fields. These innovative models hold the potential to extend MRI applications, possibly being incorporated in mobile environments like ambulances. Their reduced cost could also enable greater accessibility, especially in underprivileged communities and developing nations. However, further research is crucial to comprehend the connection between low-field images and the underlying tissue properties they represent.

Researchers at the National Institute of Standards and Technology (NIST, Gaithersburg, MD, USA) have been exploring ways to advance and validate the use of low-field MRI technology for creating images with weaker magnetic fields. In a recent study, the team employed a portable MRI machine available in the market to examine brain tissue characteristics at low magnetic field strength. They used a 64 millitesla magnetic field, significantly lower than traditional MRI machines, to image the brain tissue of ten volunteers. The MRI system was able to produce distinctive images of the entire brain, including its gray matter, white matter, and cerebrospinal fluid. Each of these brain constituents responds uniquely to low magnetic fields, generating distinct signals that offer quantitative information about each component.

Separately, NIST researchers are also investigating materials that could dramatically improve the image quality of low-field MRI scans. MRI contrast agents, which enhance image contrast, making it easier for radiologists to identify anatomical features or evidence of disease, are generally used in MRI at conventional magnetic field strengths but are relatively new in the area of low-field MRI scanners. Researchers have discovered that contrast agents behave differently at lower field strengths, indicating a potential to explore new types of magnetic materials for image enhancement.

The team at NIST tested several magnetic contrast agents' sensitivity at low magnetic fields. The findings revealed that iron oxide nanoparticles were more effective than conventional contrast agents made from gadolinium, a rare-earth metal. At low magnetic field strength, the nanoparticles yielded sufficient contrast utilizing only about one-ninth of the concentration of the gadolinium particles. Moreover, the human body can break down iron oxide nanoparticles, thereby preventing potential accumulation in tissue, unlike gadolinium, which could affect the interpretation of future MRI scans if not accounted for.

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
FMT Radiographic Suite
AdvantagePlus ML1
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
Fetal Monitor
Avante Compact II

Print article



view channel
Image: The device creates microbubbles that temporarily disrupt the BBB, permitting the entry of immunotherapy into the brain (Photo courtesy of Northwestern)

Ultrasound Technology Breaks Blood-Brain Barrier for Glioblastoma Treatment

Despite extensive molecular studies, the outlook for patients diagnosed with the aggressive brain cancer known as glioblastoma (GBM) continues to be poor. This is partly due to the blood-brain barrier... Read more

Nuclear Medicine

view channel
Image: 68Ga-NC-BCH whole-body PET imaging rapidly targets an important gastrointestinal cancer biomarker in lesions in GI cancer patients (Photo courtesy of Qi, Guo, et al.; doi.org/10.2967/jnumed.123.267110)

New PET Radiotracer Enables Same-Day Imaging of Key Gastrointestinal Cancer Biomarker

Gastrointestinal cancers rank among the most prevalent cancers worldwide, contributing to over a quarter of all cancer cases and over one-third of cancer-related deaths annually. The initial symptoms of... Read more

General/Advanced Imaging

view channel
Image: The denoised image is less noisy and the defect is more detectable and visually clearer with DEMIST (Photo courtesy of Abhinav Jha/WUSTL)

Artificial Intelligence Tool Enhances Usability of Medical Images

Doctors use myocardial perfusion imaging (MPI) single-photon emission computed tomography (SPECT) images to evaluate blood flow to the heart muscle. To capture these images, patients are administered a... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.